CBRE Stock Analysis: CBRE | NYSE
Real Estate Services | NYSE, USA | Market Cap: 43.280m USD | 12M Return: -4% | US12504L1098 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 239M
EPS Trend: 97.0%
Qual. Beats: 0
Rev. Trend: 99.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CBRE Group is a Dallas-based commercial real estate services and investment firm operating in the United States, the United Kingdom, and other international markets. The company was founded in 1906 and has been listed on the NYSE since 2004 under the ticker CBRE, currently classified as a large-cap stock in the Real Estate sector.
CBRE generates revenue through four operating segments: Advisory Services (leasing, capital markets, mortgage origination, property management, and valuation); Global Workplace Solutions (facilities and project management, including services offered under the Turner & Townsend brand); Project Management; and Real Estate Investments, which provides investment management to pension funds, insurance companies, sovereign wealth funds, and other institutional investors under the CBRE Investment Management brand, and development services under the Trammell Crow Company brand.
As a commercial real estate services firm, CBREs business model is primarily fee-based, drawing from brokerage commissions, recurring property and facilities management contracts, and asset management fees on third-party capital, rather than direct ownership of large real estate portfolios.
- Capital markets revenue rebounds as commercial property transactions accelerate
- Office leasing weakness pressures Advisory Services transaction fees
- Investment management AUM expands with rising institutional allocations
| Net Income: 1.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.17 > 1.0 |
| NWC/Revenue: 3.65% < 20% (prev 3.51%; Δ 0.15% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.36b > Net Income 1.30b |
| Net Debt (11.6b) to EBITDA (2.71b): 4.27 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (289.8m) vs 12m ago -4.31% < -2% |
| Gross Margin: 17.66% > 18% (prev 38.61%; Δ -20.96% > 0.5%) |
| Asset Turnover: 150.1% > 50% (prev 137.6%; Δ 12.47% > 0%) |
| Interest Coverage Ratio: 10.29 > 6 (EBIT TTM 2.02b / Interest Expense TTM 196.0m) |
| A: 0.05 (Total Current Assets 12.9b - Total Current Liabilities 11.3b) / Total Assets 30.5b |
| B: 0.31 (Retained Earnings 9.51b / Total Assets 30.5b) |
| C: 0.07 (EBIT TTM 2.02b / Avg Total Assets 29.1b) |
| D: 0.39 (Book Value of Equity 8.40b / Total Liabilities 21.3b) |
| Altman-Z'' = 2.24 = BBB |
| DSRI: 0.88 (Receivables 9.51b/9.46b, Revenue 43.6b/38.1b) |
| GMI: 2.19 (GM 38.61% / 17.66%) |
| AQI: 1.02 (AQ_t 0.47 / AQ_t-1 0.46) |
| SGI: 1.15 (Revenue 43.6b / 38.1b) |
| TATA: -0.00 (NI 1.30b - CFO 1.36b) / TA 30.5b) |
| Beneish M = -1.93 (Cap -4..+1) = B |
As of August 08, 2026, the stock is trading at USD 148.18 with a total of 1,425,607 shares traded. Over the past week, the price has changed by +0.93%, over one month by +3.10%, over three months by +1.01% and over the past year by -4.00%.
Current recommended Stop Loss: 140.90 (which is 4.9% or 1.6 ATR below the current price).
CBRE has received a consensus analysts rating of 4.08. Therefore, it is recommended to buy CBRE.
- StrongBuy: 5
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 180.4 | 21.8% |
P/E Trailing = 33.8145
P/E Forward = 18.7266
P/S = 0.9901
P/B = 5.1527
P/EG = 1.0522
Revenue TTM = 43.6b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 2.71b USD
Long Term Debt = 5.73b USD (from longTermDebt, last quarter)
Short Term Debt = 2.69b USD (from shortTermDebt, last quarter)
Debt = 13.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.48b
Net Debt = 11.6b USD (calculated: Debt 13.1b - CCE 1.49b)
Enterprise Value = 54.9b USD (43.3b + Debt 13.1b - CCE 1.49b)
Interest Coverage Ratio = 10.29 (Ebit TTM 2.02b / Interest Expense TTM 196.0m)
EV/FCF = 58.48x (Enterprise Value 54.9b / FCF TTM 938.0m)
FCF Yield = 1.71% (FCF TTM 938.0m / Enterprise Value 54.9b)
FCF Margin = 2.15% (FCF TTM 938.0m / Revenue TTM 43.6b)
Net Margin = 2.98% (Net Income TTM 1.30b / Revenue TTM 43.6b)
Gross Margin = 17.66% ((Revenue TTM 43.6b - Cost of Revenue TTM 35.9b) / Revenue TTM)
Gross Margin QoQ = 18.58% (prev 17.59%)
Tobins Q-Ratio = 1.80 (Enterprise Value 54.9b / Total Assets 30.5b)
Interest Expense / Debt = 1.50% (Interest Expense 196.0m / Debt 13.1b)
Taxrate = 21.15% (385.0m / 1.82b)
NOPAT = 1.59b (EBIT 2.02b * (1 - 21.15%))
Current Ratio = 1.14 (Total Current Assets 12.9b / Total Current Liabilities 11.3b)
Debt / Equity = 1.56 (Debt 13.1b / totalStockholderEquity, last quarter 8.40b)
Debt / EBITDA = 4.27 (Net Debt 11.6b / EBITDA 2.71b)
Debt / FCF = 12.34 (Net Debt 11.6b / FCF TTM 938.0m)
Total Stockholder Equity = 8.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 1.30b / Total Assets 30.5b)
RoE = 15.16% (Net Income TTM 1.30b / Total Stockholder Equity 8.58b)
RoCE = 14.08% (EBIT 2.02b / Capital Employed (Equity 8.58b + L.T.Debt 5.73b))
RoIC = 7.81% (NOPAT 1.59b / Invested Capital 20.4b)
WACC = 6.79% (E(43.3b)/V(56.3b) * Re(8.48%) + D(13.1b)/V(56.3b) * Rd(1.50%) * (1-Tc(0.21)))
Discount Rate = 8.48% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.63 | Cagr: -1.68%
[DCF] Terminal Value 73.10% ; FCFF base≈1.03b ; Y1≈906.1m ; Y5≈732.1m
[DCF] Fair Price = 0.62 (EV 11.8b - Net Debt 11.6b = Equity 178.3m / Shares 289.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.99 | EPS CAGR: 32.70% | SUE: 0.66 | # QB: 0
Revenue Correlation: 99.64 | Revenue CAGR: 13.32% | SUE: -0.32 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.90 | Chg30d=+2.77% | Revisions=+29% | Analysts=9
EPS current Year (2026-12-31): EPS=7.76 | Chg30d=+1.21% | Revisions=+29% | GrowthEPS=+21.7% | GrowthRev=+15.9%
EPS next Year (2027-12-31): EPS=9.04 | Chg30d=+2.00% | Revisions=+0% | GrowthEPS=+16.4% | GrowthRev=+11.0%
[Analyst] Revisions Ratio: +27% (up=8, down=4)